surmount 2 tirzepatide SURMOUNT-3 study design This is a phase 3, multicenter, randomized, tirzepatide surmount trials once weekly

These conditions, along with thyroid tumors, may signal an increased risk when using GLP-1 medications

for more details, see Sampson et al., 2021 13

15 Amino acid peptide sequence derived from body protective compound Multi Tissue healing supportgut, tendons, ligaments, muscles, and more Questions BPC-157 is administered via subcutaneous injection into the fatty tissue beneath the skin, or in some cases, intramuscularly near the injury site

Description SUPPORTS YOUR GLP-1 JOURNEY If you're taking a GLP-1 medication, you know it can come with like low energy and digestive discomfort

META Multi helps fill common nutrient gaps associated with GLP-1 use

Your Fatigue May Be a Sign of Healing Feeling tired when starting GLP-1 therapy does not automatically indicate a problem